The salient properties of laser light and the way light interacts with biological tissues and molecular constituents of tissues offer possibilities for detection and diagnosis of cancer. In particular, the wavelength selectivity of tunable lasers, narrow bandwidth around the selected wavelength, and spectral brightness enable probing of key molecular constituents of tissues, and endow laser-based techniques with much desired diagnostic potential. This article presents an overview of some recent developments in optical imaging and optical biopsy of different types of cancers, and illustrates the diagnostic role of the color of light.
Introduction
Advances in physical sciences and technology often impact medicine in profound ways. Many of the modern modalities such as, x-rays, magnetic resonance, ultrasound, nuclear radiation, and linear accelerators that revolutionized the way doctors peer inside human body to detect and diagnose diseases and sometimes treat those owe their origin to developments in physical sciences. Light, and in particular laser light, has the potential to play an important role in cancer detection, diagnosis, and treatment. The laser light is characterized by high degree of directionality, monochromaticity, coherence, and spectral brightness. These properties make lasers suited for probing body functions, physiology, and tumors in human body organs (1), and offer the promise for development of a new generation of laser-based modalities and techniques for detection and diagnosis of diseases.
In this article we present a brief overview of the emerging uses of laser light in detection and diagnosis of breast and prostate cancers, elucidate the salient characteristics that make light a versatile tool for these applications, and cite a few illustrative examples. The intent is to introduce medical professionals (who may not be active in the area of lasers and biomedical optics) to these important developments. Illustrative examples are drawn from the work readily available to the authors. A comprehensive review of the status of the field is beyond the scope of this article, but major research efforts are introduced by way of references. The article does not deal with photodynamic therapy (2), a novel application of lasers that combines a photosensitizer with laser light of specific wavelengths to treat tumors located on the surface or just below the surface of skin or the lining of internal body organs (3). Use of lasers in the treatment of superficial cancers, such as, basal cell skin cancer, and early stages of cervical, penile, vaginal, vulvar, and non-small cell lung cancer is not covered as well (4).
Monochromaticity of a laser beam refers to its linewidth being much narrower than conventional light source. High degree of directionality enables generation of intense, collimated beams of light. Spectral brightness, the optical power flow per unit bandwidth per unit solid angle and unit area of the source, is orders of magnitude higher even for low-power laser beams than the high-power conventional light beams. Biological tissues attenuate light strongly through scattering and absorption processes. Above-mentioned properties of laser light are essential for probing of targets deep inside biological tissues. Broadly tunable lasers enable selection of narrow-bandwidth beams of spectrally bright light at desired wavelengths for probing key molecular constituents to obtain potential diagnostic information. The ability of ultrafast lasers to generate picosecond and femtosecond duration pulses enable time-resolved optical imaging of structures in biological tissues, and study of the dynamical processes in key chromophores, and thus provide additional advantages for disease detection and diagnosis.
The past two decades have witnessed a rapid growth in the research activities to exploit the wavelength selectivity, spectral brightness, coherence, and other salient characteristics of laser light to peer inside body organs and sense physiological functions (1). These research activities and developments in the use of light for detection and diagnosis of cancers may be broadly classified into two broad categories, optical biomedical imaging and optical biopsy (5). The selection of laser light at appropriate wavelengths plays the most important role in the realization of biomedical applications. Optical imaging requires that a significant fraction of the probing light emerge from the target body organ to provide interior information. Near-infrared light (NIR) in the "therapeutic window" of 700-1300 nm is suitable for this application. Strong absorption by blood and protein molecules in the body limits the therapeutic window at the short-wavelength end, while that by water limits it at the long-wavelength end. Optical biopsy, on the other hand, commonly makes use of near-ultraviolet and blue-green light in the 300-500 nm range for resonant excitation of selective protein molecules, and investigation of their light absorption and emission characteristics to monitor disease-induced changes in tissues.
The goal of the optical biomedical imaging research is to develop noninvasive methods and techniques to detect tumors in body organs at early stages of growth, and preferably to identify those as malignant and benign. Optical biopsy techniques seek rapid, minimally invasive in situ diagnosis of diseases using spectroscopic signatures without tissue removal. Key wavelengths are used to probe molecular changes in tissues. Optical imaging and optical biopsy techniques make use of the differences in optical and spectroscopic properties between normal tissues, benign tumors, as well as, pre-cancerous and cancerous tissues. Light interacts with biological tissues through a variety of processes that include reflection, refraction, absorption, emission, as well as, elastic and inelastic scattering. In addition there are the nonlinear optical interactions of multi-photon absorption and higher harmonics generation. Nonlinear optical interaction based techniques can make use of NIR light as probe for deeper penetration, and monitor the signal at shorter wavelengths for which detectors with higher sensitivity are available. Elastic scattering, absorption, and fluorescence are dominant among these interactions. Elastic scattering (henceforth referred to as scattering unless otherwise noted) of light provides information about the size of organelles in cells, index of refraction variation, and structural inhomogeneity in tissues, while absorption and fluorescence indicate molecular changes in tissue constituents.
Absorption spectra of a number of molecular constituents of biological tissues, such as, proteins, amino acids, water, oxyhemoglobin, deoxy-hemoglobin, and fat covering the nearultraviolet to the mid-infrared spectral range are displayed in Figure 1 (a) (6). cule emits light in a characteristic spectral range when excited into its absorption band, as shown in the fluorescence spectra presented in Figure 2 . These absorption and fluorescence spectra indicate how selection of appropriate wavelengths can be used for spectroscopic probing of one or more of these constituents to obtain useful detection and diagnostic information about cancer development.
The interest in developing light-based medical imaging and diagnostic techniques derives from several favorable characteristics of optical approach. Light is a non-invasive (or minimally invasive), non-ionizing radiation, so that, use of light for routine screening poses little health hazard. Optical biopsy can be carried out in situ, without removal of tissue, and may be developed to be a near realtime modality. Optical imaging has the potential to complement x-rays for detection of breast tumors, especially for young dense breasts that happen to be problematic for commonly used x-ray mammography. Optical imaging has diagnostic potential, since use of NIR light of different wavelengths enables probing of molecular spectroscopic signatures of oxy-hemoglobin, deoxy-hemoglobin, water, and lipids. Finally, optical approach can provide information about body function through the monitoring of any spectroscopic changes associated with the function, such as, blood oxygenation and de-oxygenation.
Breast cancer is the second major cause of death among US female population. One in eight women in North America develops breast cancer during her lifetime. The estimated death toll from breast cancer is 40,111 and new cases of invasive breast cancer are 215,919 in the year 2004 alone (7). On the other side of the gender line, approximately 180,000 new cases are diagnosed, and 37,000 deaths result from the prostate cancer every year among the male population in the U.S (8). Prompt, noninvasive, early detection of these cancers is urgent, and optical approaches are being pursued to address this need.
In the following sections, we highlight some of the optical imaging and optical biopsy techniques.
Optical Imaging

Background
The objective of any biomedical imaging technique is to identify, locate, and diagnose a 'target,' such as a tumor, inside a body organ, such as, breast, cervix, prostate, and oral cavity. In its simplest form, an optical imaging procedure would involve illuminating the part of the body to be imaged with bright light and to search for indication of pathology in the observed transillumination pattern. The physical basis of transillumination is the difference in the transmission of light through normal tissue and tumors or lesions inside it. This differential transmission, in principle, should lead to the formation of a 'shadow' of the tumor in transmitted light. However, a biological tissue strongly scatters the light that passes through it. The scattered light severely degrades the quality of the shadow image, and for thick tissues, may bury it in background noise. Absorption of light by tissues attenuates useful signal. The key to the successful development of optical imaging techniques is to select light of appropriate wavelengths that is not strongly absorbed by tissues, and to deal with the problem of light scattering effectively. Near-infrared spectral range of 700-1300 nm is more commonly used because light in this window is less absorbed by and can penetrate deeper into tissues than the visible and infrared light.
Scattering changes the characteristics such as intensity, coherence and polarization of the incident light, so that, the light that emerges from the medium has very different characteristics than that of the incident light. The extent of these changes depends on the wavelength of light, the type of tissue through which it propagates, and the tissue thickness. The transmitted light comprises three components, commonly referred to as the ballistic, snake (or mildly-scattered), and diffuse (or, multiple-scattered) photons (9, 10). The ballistic or coherently forward-scattered photons propagate in the incident direction, traverse the shortest path, arrive early in time, and can form direct 'shadow' image of a target whose optical properties are different from the intervening medium. The diffuse light consists of multiple-scattered photons that travel long distances within the medium, loses the coherence and polarization memory of the incident beam, and emerges later in all directions. It cannot form direct shadow images, but carries indirect image information about the tissue interior that has to be extracted by clever experimental, analytical and/or numerical tools. The snake photons scatter paraxially in the forward direction, arrive after the ballistic photons, and partially retain the coherence and polarization of the incident light beam. The geometrical distribution of scattered light depends on how the size, a, of the scattering entities compare with the wavelength, λ, of light. Light is more forward scattered for large particles, a > λ, than for small particles, a << λ.
Scattering makes the photons of an incident short pulse of light spend different times in transit through the intervening medium. So, the transmitted pulse becomes temporally broadened with the ballistic photons arriving first, followed by the snake and diffusive photons. Ballistic photons are the most effective in forming shadow image. Snake photons that arrive much earlier than the diffuse photons also generate well-defined transillumination images. The ballistic and snake components are the direct "image-bearing" photons.
The intensity of the forward-transmitted light is strongly attenuated by absorption and scattering within the sample.
The techniques used to sort out the image-bearing photons for direct imaging exploit one or more of the changes that scattering induces on the characteristics, such as, directionality, polarization, coherence, and temporal duration of the incident light. Since the image-bearing photons change the least, the idea is to devise a gate that will let the photons with a specific initial property through but block others. There are time, space, coherence, polarization, and absorption gates (1, 10-16). A space gate (12) exploits the fact that the ballistic and snake photons come out of the tissue in the incident direction, while the multiple-scattered light emerges in all directions. So, a small aperture centered on the line of incidence and placed after the sample will collect the on-linetransmitted light and effectively discriminate against most of the off-axis scattered light. A time gate (10, 11) capitalizes on the fact that image-bearing photons emerge from the sample sooner than the diffusive photons. To realize a time gate in practice one then needs a shutter that will open for a short duration, typically a few picoseconds, to let the early photons through and then close in time to leave out the delayed scattered photons. Similar gating schemes based on coherence (13, 14) and polarization (15) of light have also been devised. Often a single gate may not be discriminating enough. For example, a space gate cannot filter out the photons that have first been scattered out of the incident direction and then back into it. However, a time gate employed after the space gate can cut out such "on-line" scattered photons, since scattering makes them travel longer distances and emerge out of the sample later than the image-bearing photons.
The implementation of an optical imaging modality based on any of the gating methods mentioned above requires an appropriate light source and beam delivery optics to illuminate the sample, a detection scheme to monitor the transmitted light, and a signal processing unit to construct the image from the collected data and known experimental parameters.
The form in which data should be collected is a major consideration, and three different approaches -time resolved, frequency domain and continuous wave -are in use (1, (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) While the results are promising, the ultimate goal of high spatial resolution and genuine diagnostic ability still remains elusive. The time-resolved approach has higher potential to enhance resolution since time-resolved measurements provide data over a multitude of frequencies that is essential for high-resolution image reconstruction. However, it is the diagnostic potential that makes optical mammography attractive over x-ray mammography that provides the best spatial resolution. Spectroscopic imaging offers that diagnostic potential, since the wavelength of light can be tuned to molecular changes in tissue constituents that are associated with cancer.
The key is to identify those changes, and the wavelengths needed to interrogate the effects of those changes.
In the following sections, we present some salient results of imaging measurements carried out on normal and cancerous breast and prostate tissues that illustrate the use of some of these imaging techniques, and the need for wavelength selection.
Time-resolved Imaging of Normal and Cancerous Breast Tissues
A typical experimental arrangement for time-sliced imaging makes use of approximately 120-fs duration, 1-kHz repetition-rate, 800-nm light pulses form a Ti-sapphire laser and amplifier system for sample illumination, and an ultrafast gated intensified camera system (UGICS) for recording transmitted light and forming 2-D images (21, 28). The UGICS system consists of a gated image intensifier fiber optically coupled to a charge coupled device (CCD) camera.
It provides an 80-ps time gate whose position can be varied over a 20 ns range, and enables recording of a timesequenced series of 2-D images.
Time-resolved images of a 5-mm thick ex vivo breast tissue specimen comprising a normal part, and a part with infiltrating ductal carcinoma for different positions of the time gate are displayed in the left frames of Figure 3 . Corresponding spatial intensity profiles integrated over the same horizontal area for all the images are shown in the right frames. The salient feature of the images and the intensity profiles is the higher light transmission through and highlighting of the cancerous region at early times. At much later times, the situation reverses and more light arrives through the normal tissue than the tumor. The observed time-dependent difference in light transmission is attributed to differences in light scattering by normal tissue and tumors. The researchers reproduced this behavior on a number of ex vivo breast tissue samples obtained from patients of different age and tumors in different stages of growth (22, 43). These results indicate that time-resolved optical imaging can differentiate between normal breast tissue and tumors.
Spectroscopic Imaging of Breast Tissues
Diagnostic potential of optical imaging may be realized by making use of the spectroscopic signatures of tissue constituents and chromophores. In a proof-of-the-principle experiment, images of a normal human breast tissue specimen comprising adipose tissue in the middle, and fibrous tissues on the two sides were recorded using light in the 1225 to 1300 nm wavelength range (22, 43, 44) . Some of the wavelengths used were near resonant with the adipose tissue absorption at 1203 nm (45), while the other wavelengths were far removed from the resonance. The left frames of recorded using the near-resonant wavelength of 1225 nm and the off-resonance wavelength of 1300 nm. A Cr 4+ :Forsterite laser was used as the light source, a Fourier space gate and a polarization gate were used for partial discrimination of highly scattered photons, and a 128 × 128 pixels InGaAs NIR area camera was used for recording 2-D images using transmitted light. Corresponding spatial intensity profiles of the images obtained by integrating over the same horizontal area for all the images are shown in the right frames. The salient features of the images are that the adipose tissue appears much darker (less light transmission) than the fibrous tissues in the near-resonant 1225 nm image compared to that for the 1300 nm image. The adipose region appears as a trough in the resonant 1225-nm profile. No such distinction is observed in the non-resonant 1300-nm profile, which follows the intensity distribution of the probing laser beam. These results demonstrate that a spectroscopic difference between different types of tissues in a breast tissue sample provides distinguishable signature in the optical image.
While the example presented here pertains to direct imaging based on optical absorption by adipose tissue around 1210 nm, other researchers have used wavelengths in the 600-1000 nm range to probe oxy-hemoglobin, de-oxyhemoglobin, oxygen saturation, water, and lipids for reconstruction of breast optical properties (33-39, 46).
Near-infrared Spectroscopic Imaging of Normal and Cancerous Prostate Tissues
The diagnostic potential of spectroscopic imaging was further demonstrated using the difference in light absorption by normal and cancerous prostate tissues at certain key wavelengths that corresponded to absorption resonances of water (47). Water concentration can be higher in normal prostate tissues than in cancerous prostate tissues. Light attenuation due to absorption will be higher in normal prostate tissue than in cancerous prostate tissue of same thickness.
The experiment involved illuminating a 30 mm × 20 mm × 300 µm ex vivo prostate tissue sample containing normal and cancerous parts with linearly polarized broadband light centered on water absorption peaks and recording 2-D images using a near-infrared area camera (47). Images were recorded using components of transmitted light polarized parallel and perpendicular to the polarization of the incident light beam. Figure 5 (a) is that the cancerous right side appears much brighter than the normal left part, indicating higher transmission of light through the cancerous part. The spatial intensity profile of Figure 5 (b) shows approximately 50% higher peak transmission through the cancerous region than through the normal region. The same feature was reproduced for five different prostate tissue specimens with normal and cancerous parts, as well as for images measured with light of other wavelengths that overlap with water absorption peaks. Since the tissue specimen had the same thickness throughout, the relative brightness (higher transmission) of the cancerous part is attributed to lower absorption of light by the cancerous part than the normal part. The contrast between the two parts disappeared when light of a wavelength away from any water absorption resonance was used. Although this result was obtained using filtered light from a lamp, for thick tissues or for in vivo measurements laser light with much higher spectral brightness at the appropriate wavelengths will be more suited.
While the direct imaging approaches presented above demonstrate the potential, a direct in vivo image of a tumor inside the breast or prostate may not be feasible since the tumor may be located at distances well above the direct observation limit of 10 transport mean free paths (40). As mentioned in Background, researchers are resorting to the alternative image reconstruction approach that makes use of the knowledge of the characteristics of input light, measured distribution of light intensity that emerges from the illuminated tissue, and a theoretical model that describes how light propagates through biological tissues to construct an image of the interior of breast or prostate. This is an active area of contemporary research that needs developments of suitable light sources, detectors and other instrumentation for accumulation of useful data in reasonable times, and an adequate theoretical formalism for obtaining unique solutions to the inversion problem (25-39). Here again reconstructed images using data recorded at different key wavelengths can provide diagnostic information (34, 35, 46) .
Optical Biopsy
Optical biopsy techniques commonly make use of the differences between the absorption, excitation, emission, and Raman spectra of tissues in the suspect region of the body organ. Absorption and emission of light by tissues involve a combination of resonant electronic, vibrational, and rotational transitions between the quantum states of tissue constituents. Raman spectra commonly arise from inelastic scattering of light involving vibrational transitions in molecules. Optical biopsy based on absorption and fluorescence spectra makes use of near-ultraviolet and visible light for probing the protein and amino acid molecules in the tissue. Light in this spectral range is strongly absorbed by tissue constituents, so surface and subsurface (depth < 1 mm) molecules are normally probed.
Any spectrum of a tissue is generally a weighted superposition of the spectra of some key constituent molecules of the tissue. Some of the important molecular constituents of tissue include water, lipids, tryptophan, collagen, elastin, flavins, oxy-hemoglobin, deoxy-hemoglobin, and nicotinamide adenine dinucleotide (NADH). Absorption spectra and emission spectra of some of these constituents have been presented in Figure 1 and Figure 2 , respectively. Cancer involves changes in the structure, composition, and relative concentration of different tissue constituents, which in turn may alter the spectral characteristics. These spectral changes may include changes in intensity and/or line shape, and provide the physical basis for optical biopsy (48).
Fluorescence and Excitation Biopsy
Native tissue fluorescence (no extrinsic agents, such as, a fluorescent dye added) spectroscopy has been demonstrated to be an accurate method for distinguishing malignant tumors from normal tissues (49, 50) An emission (or, fluorescence) spectrum is a plot of the intensity of the emitted light as a function of wavelength. The emission of light follows excitation of the specimen from its ground state to one of its excited states by some means, which often include absorption of light. An absorption spectrum measures the attenuation of a beam of incident light and is a plot of absorption coefficient, α(λ) = ln (I 0 /I)/L, as a function wavelength, λ where I 0 and I are the incident and transmitted light intensities, respectively, and L is the sample length. While absorption spectra provide information about excited energy states of the specimen relative to the ground state, fluorescence spectra carry information about the lower-lying states relative to a higher-energy excited state. A plot of the intensity of the light emitted at a particular wavelength as a function of the wavelength of the exciting light is an excitation spectrum that provides similar information as that of an absorption spectrum, but is much more sensitive, applicable for turbid samples, and can be used for separating out the contributions of fluorophores with overlapping absorption characteristics. Alfano and co-workers were first to apply fluorescence spectroscopy to identify malignancy (49). Early investigations used animal tissues and 488-nm Ar + -laser excitation (49). The method was later extended to in vitro (49-51) and in vivo (52) human tissues using other key wavelengths.
Various differences in the visible and ultraviolet spectra of malignant tumors and normal tissues were noted. While the difference in the normalized emission intensity between the normal and cancerous tissues was small around 340 nm, it was substantial around 440 nm. This feature led to the development of the ratio test (53), which demonstrated that under 300 nm excitation, the ratio of intensity of emission at 340 nm to that at 440 nm, I 340 /I 440 , was significantly different for malignant tumors compared to that for benign tumors and normal tissues. The difference in ratio was observed for both breast (53) and gynecological (54) tissue samples. An average of the emission spectra for a large number of normal and malignant breast tissue samples is shown in Figure 6 , which clearly demonstrate the difference in the I 340 /I 440 ratio. The 340 nm emission is probably from tryptophan, while the 440 nm emission probably includes contributions from collagen, elastin, and NADH. The 340 and 440 nm wavelengths are significant because light absorptions by blood at these wavelengths are nearly equal.
Fluorescence biopsy has been applied to in vivo diagnosis of colon and gynecological tract cancers by various researchers (52-55). The accuracy of this method for in vivo results was shown to be comparable to that of pathology (20). Sensitivity between 80%-97% has been reported by various research groups (54,55).
Fluorescence spectroscopy can be used for the development of a wide range of non-invasive, optical fiber-based diagnostic tools for in vivo and in vitro tissue examination. The high spatial resolution of optical systems can allow for the detection of small cancerous or pre-cancerous conditions, while fiber optic probes allow for investigation inside the body, with or without needles. Another important area of development is fluorescence from contrast agents (organic dyes and quantum dots) that attach selectively to tumors and enable in vivo imaging and diagnosis (56, 57). Several companies, such as, Spectrx, Headwall Photonics, MediSpectra, and Mediscience Technology Corp. are involved in developing and marketing optical biopsy devices for clinical applications.
Stokes Shift Emission Biopsy
An interesting variation of the fluorescence and excitation biopsy is the recently introduced Stokes shift emission (SSE) biopsy that makes simultaneous use of the absorption and fluorescence spectroscopy (58, 59). In fluorescence spectroscopy, molecules of a fluorophore are excited using light at a fixed wavelength and the emitted light intensity is monitored as a function of the wavelength of the emitted light. An excitation spectrum plots the intensity of light emitted at a fixed wavelength as a function of the wavelength of the excitation beam which scans the spectral range over which the fluorophore absorbs light. SSE spectroscopy monitors the intensity of emitted light that is red shifted by a fixed wavelength difference (∆λ) or frequency difference (∆ν) from the excitation beam, as the wavelength of the excitation beam is scanned across the absorption spectral range of the specimen. A SSE spectrum is then a plot of the fluorescence intensity, I F (λ em ) [or I F (ν em )] vs. λ em (or ν em ), where λ em = λ ex + ∆λ, is the emission wavelength (ν em = ν ex -∆ν, is the emission frequency), and the excitation wavelength, λ ex (or ν ex ), is varied over the absorption spectral range. The approach derives its name from Stokes shift, which is the separation (∆λ m or ∆ν m ) between the absorption and emission peaks of the molecule. The strength of a SSE spectrum depends on the shift, ∆λ (or ∆ν), and is optimal when the shift is equal to the Stokes shift, ∆λ m (or ∆ν m ).
The SSE spectra can be much more revealing and sensitive than common fluorescence spectra when the specimen contains a number of different fluorophores with partially overlapping absorption and/or fluorescence spectra. As shown in Figure 1 (b) and Figure 2 , the proteins and amino acids in tissues are characterized by absorption and emission spectra that have significant overlap. The composite fluorescence spectra of normal and cancerous human breast tissues, displayed in Figure 6 , differ significantly in intensity, but not appreciably in structure and lineshape. In contrast, the SSE spectra displayed in Figure 7 (a) reveal two distinct peaks at 294 nm and 340 nm. What is even more interesting is that the 294-nm peak is much more intense than the 340-nm peak for the cancerous breast tissue, while the situation is reversed for the normal tissue. Consequently, the ratio of the intensities at the two wavelengths, R = I 294 /I 340 , has a much higher value for cancerous tissues than the normal tissues, and may serve as an indicator for cancer. To explore the feasibility even further, the ratio values were measured for a num-ber of normal tissues and tumors from different patients.
The ratio values, plotted in Figure 7 (b), clearly demonstrate the trend that the value of R is consistently higher for tumors than for the normal tissues. The critical value, R C = 3.5 may be considered to be the dividing line between normal and cancerous tissues. The value of R may be indicative of the stage of development of the cancer. Meticulous measurements with a large number of tissues at different stages of tumor growth will be needed to assess the critical value, as well as, the accuracy and specificity of this approach.
Raman Biopsy
Another optical biopsy approach that has received much attention is based on Raman scattering, an inelastic light scattering process that provides information about the vibrational energy levels of molecules. In a Raman spectrum, the intensity of light scattered from a sample is plotted as a function of energy difference ('Raman shift') between the incident photons and inelastically scattered photons. The Raman shift is equal to the energy difference between the final and the initial vibrational states of the molecule participating in the process. A typical Raman spectrum consists of spectrally narrow (a few wave numbers) 'Raman peaks' that are better defined than the typical broadband tissue fluorescence. The Raman peaks are generally associated with the normal modes of vibration of different chemical bonds and functional groups of a molecule. Raman spectra of important biological molecules consists of sharp Raman peaks in the 'fingerprint spectral region' that extends from a Raman shift of 700 to 1900 cm -1 (60). These characteristic spectra may be used to identify a particular molecule in a sample, or alternately to generate information about the constituents of a composite sample. The changes in the Raman spectra of a tissue brought about by the onset of a disease provide the physical basis for Raman biopsy. The higher spectral resolution, low signal level, and complex structure of Raman spectra require a laser as the excitation source. For ultraviolet and visible excitations, strong tissue fluorescence generally overwhelm weak Raman signal. So, Raman spectra need to be measured using near-infrared (NIR) excitation in order to minimize the background fluorescence. Reference 60 provides a comprehensive review of biomedical applications of Raman scattering with emphasis on cancer diagnosis.
Future Developments
Advances in optical biopsy and optical imaging techniques will lead to new modalities for disease detection and diagnosis. The organs of human body with potential to be investigated by these techniques include breast, brain, bladder, bone, cervix, colon, eye, digestive and gynecological tracts, prostate, and skin. The brief overview presented above demonstrates that detection of diseases and imaging of body organs using light at appropriate wavelengths are apt to making a transition from scientific curiosity to useful clinical technologies. However, much work need be done for the realization of the clinical potentials of optical biopsy and optical imaging techniques. The issues to be addressed for developing an optical imaging modality for a particular application include evaluation of relative merits of available approaches, selection of key diagnostic wavelengths, sources to generate and detectors to monitor light at those wavelengths, and accumulation of data on optical, spectroscopic, and transport properties of tissues and organs. In optical biopsy, a detailed understanding of the macroscopic, microscopic and molecular origins of spectroscopic signals and how those are altered under diseased conditions need to be understood. Concerted efforts of dedicated researchers will help reach the coveted goals.
